BioSpace News Archive

Kala Pharmaceuticals, Inc. (Kala) (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY™ mucus-penetrating particle (MPP) Drug Delivery Technology, today announced that it has completed enrollment in its STRIDE 3 (STRIDE – Short Term Relief In Dry Eye) Phase 3 clinical trial for KPI-121 0.25%, its product candidate for the short-term treatment of dry eye disease.

Walgreens is supporting relief efforts in Puerto Rico as many communities work to recover in the aftermath of earthquakes that impacted the region last week.

Xtraction Services Holding Corp. (“Xtraction Services,” “XS” or the “Company”) (CSE:XS) (OTCQB:XSHLF), a specialty finance company engaged in equipment leasing in the United States, is pleased to announce that OTC Markets Group Inc. has approved the trading of Xtraction Services shares on the OTCQB Venture Market.

Nimrodi Will Lead the Company’s Accelerated Growth as It Launches Custom and Standardized Panel Assays to Be Used by Its Expanding Installed Base.

Biomerica announced a net loss for the three months ended November 30, 2019 of $485,260, or $0.05 per share, versus a net loss of $477,244, or $0.05 per share, in the previous fiscal year during the same quarter.

NanoFlu™ is its recombinant quadrivalent seasonal influenza vaccine candidate, adjuvanted with Matrix-M™, in adults 65 years of age and older.

KemPharm’s Common Stock Listing Transfers to The Nasdaq Capital Market Effective Today

Under the grant, researchers from the University’s Center for Drug Design, College of Pharmacy, and Massachusetts-based pharmaceutical company Windgap Medical are collaborating to design an autoinjector.

ReAction® is quickly becoming a leader in the Hemp industry by providing safe, reliable, powerful Products backed up by its exclusive Team of expert My Life’s Simple™ Direct Sales Ambassadors.

Eric Bartenstein Named Chief Underwriting and Digital Officer